Understanding the mechanism helps explain why opioid use disorder is a medical condition with a physical basis, not simply a matter of willpower.
Opioid receptors
The brain and body have several types of opioid receptors — mu, kappa, and delta are the main ones. Most opioids used for pain relief and most opioids misused recreationally act primarily on mu-opioid receptors. These receptors are part of a system your body already uses on its own, via naturally produced substances called endorphins — opioid drugs essentially hijack a system that already exists for pain relief and reward.
Why opioids feel the way they do
Activating mu-opioid receptors reduces pain signals and triggers the release of dopamine in the brain’s reward circuitry — the same circuitry involved in other survival-related rewards like eating and social connection. This dual action (pain relief plus reward) is part of why opioids are both clinically useful and prone to compulsive use.
Why the body adapts — tolerance
With repeated exposure, the brain adjusts: it reduces the number or sensitivity of opioid receptors, and ramps up other systems to compensate for the constant presence of the drug. This is tolerance — the same amount produces less effect over time, so more is needed for the same result. [tolerance article]
Why stopping causes withdrawal
Because the brain has adapted to expect opioids being present, removing them suddenly leaves those compensating systems unopposed — this rebound effect is what withdrawal actually is, physiologically. It’s not “in someone’s head”; it’s a predictable, physical consequence of how the brain adapted.
Why this matters for treatment
Medications for opioid use disorder work with this same receptor system. Buprenorphine partially activates the same receptors (reducing withdrawal and cravings without producing a strong high once stabilized), methadone fully activates them in a controlled, long-acting way, and naltrexone blocks the receptors entirely, preventing opioids from having an effect. None of these are “replacing one drug with another” in a meaningful sense — they’re addressing the same receptor system that’s already been altered by opioid use, in a way research shows substantially improves survival.
Medically reviewed by [pending]. Sources: NIDA, NIH.